The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
Fighting Against Chinese & Indian Generic Pharmaceutical Manufacturers Exporting Unsafe Products to the U.S. WASHINGTON — The Coalition for a Prosperous America (CPA) today announced the launch of Americans for Safe Drugs©, a new campaign fighting against foreign generic pharmaceutical manufacturers in China and India that are flagrantly violating the Food and Drug Administration’s (FDA)…
A House committee hearing on the FDA focused on diversity in clinical trials, fast approval for cancer drugs, and no word on foreign vs domestic generic pharmaceutical labs.
Sen. Tina Smith’s bill to provide $500 million in grants for domestic pharmaceutical manufacturers passes with flying colors and will be part of PREVENT Pandemics Act.
The House Committee on Energy and Commerce discussed FDA’s user fee budget and what can be done to reshore more of the pharmaceutical industry.
CPA sent the following letter to House Speaker Nancy Pelosi (D-CA) and Minority Leader Kevin McCarthy (R-CA) regarding the Office of the Attending Physician’s distribution of KN95 masks made in China to lawmakers. CPA urged House leadership to immediately stop all purchase and procurement of Chinese personal protective equipment (PPE) and instead source from American…
Recent supply chain bottlenecks of hospital gear shows why continued dependence on Asia is bad for pandemic preparedness. The Make PPE in America Act in the infrastructure law should remedy this in the years ahead, if Congress doesn’t open the doors to duty-free PPE and undercut the law’s intent.
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded U.S. Senators Sherrod Brown (D-OH) and Tammy Baldwin (D-WI) for leading a letter to United States Trade Representative (USTR) Katherine Tai requesting that 301 penalty duties be assessed to all imported finished state personal protective equipment (PPE) and key raw material inputs, including single-use…
CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole in the Hatch-Waxman Act has led to generic drug shortages in the U.S., offshoring of America’s domestic production of generic pharmaceuticals to China and India, and price gouging by foreign…
